What is the status of full approvals for Bharat Biotech’s Covaxin?
Answer
Answer
India’s first indigenous vaccine against Covid-19, Covaxin by Bharat Biotech, has just showed 77.6% efficacy in the final analysis of phase-3 clinical trials. The vaccine showed 93% efficacy rate against severe diseases and an impressive 60% efficacy against asymptomatic COVID-19. The final findings were presented before the Subject Expert Committee of DCGI and will also be presented to the WHO.